Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 67.94% is 89% above its 5-year average of 35.95%, near the high end of its 5-year range (15.16%–67.94%).
As of the fiscal period ended Wednesday, December 31, 2025. 29.19% above its 12-month average of 52.59%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
67.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
52.59%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
46.08%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
35.95%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
22.88%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+29.19%
CURRENT VS 3Y AVG
+47.44%
CURRENT VS 5Y AVG
+88.98%
CURRENT VS 10Y AVG
+196.98%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+696.48%
vs the sector median at left
Medpace Holdings, Inc.
Market Cap
$16.11B
Return on Invested Capital (ROIC)
67.94%
TTM Avg
52.59%
3Y Avg
46.08%
5Y Avg
35.95%
Market Cap
$15.41B
Return on Invested Capital (ROIC)
10.58%
TTM Avg
10.99%
3Y Avg
9.48%
5Y Avg
9.31%
Market Cap
$16.97B
Return on Invested Capital (ROIC)
7.35%
TTM Avg
8.59%
3Y Avg
9.78%
5Y Avg
13.56%
Market Cap
$14.80B
Return on Invested Capital (ROIC)
17.76%
TTM Avg
12.30%
3Y Avg
11.68%
5Y Avg
9.70%
Market Cap
$14.10B
Return on Invested Capital (ROIC)
3.98%
TTM Avg
4.09%
3Y Avg
3.90%
5Y Avg
4.29%
Market Cap
$18.17B
Return on Invested Capital (ROIC)
5.48%
TTM Avg
5.58%
3Y Avg
5.01%
5Y Avg
3.94%
Market Cap
$13.52B
Return on Invested Capital (ROIC)
-1.79%
TTM Avg
-0.86%
3Y Avg
-2.61%
5Y Avg
0.30%
Market Cap
$12.55B
Return on Invested Capital (ROIC)
2.82%
TTM Avg
2.97%
3Y Avg
3.42%
5Y Avg
5.50%
Market Cap
$12.11B
Return on Invested Capital (ROIC)
9.94%
TTM Avg
9.96%
3Y Avg
10.13%
5Y Avg
11.66%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | $16.11B | 67.94% | 52.59% | 46.08% | 35.95% |
| DaVita Inc. (DVA)vs › | $15.41B | 10.58% | 10.99% | 9.48% | 9.31% |
| Hologic, Inc. (HOLX)vs › | $16.97B | 7.35% | 8.59% | 9.78% | 13.56% |
| Solventum Corporation (SOLV)vs › | $14.80B | 17.76% | 12.30% | 11.68% | 9.70% |
| The Cooper Companies, Inc. (COO)vs › | $14.10B | 3.98% | 4.09% | 3.90% | 4.29% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.17B | 5.48% | 5.58% | 5.01% | 3.94% |
| Baxter International Inc. (BAX)vs › | $13.52B | -1.79% | -0.86% | -2.61% | 0.30% |
| Revvity, Inc. (RVTY)vs › | $12.55B | 2.82% | 2.97% | 3.42% | 5.50% |
| Align Technology, Inc. (ALGN)vs › | $12.11B | 9.94% | 9.96% | 10.13% | 11.66% |
| Viatris Inc. (VTRS)vs › | $20.45B | -7.95% | -3.96% | -1.19% | -0.87% |
ROIC
67.9%
ROE
113.3%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 67.94% |
| 2024-12-31 | 37.24% |
| 2023-12-31 | 38.78% |
| 2022-12-31 | 40.36% |
| 2021-12-31 | 16.23% |
| 2020-12-31 | 15.16% |
| 2019-12-31 | 12.80% |
| 2018-12-31 | 11.07% |
| 2017-12-31 | 5.75% |
| 2016-12-31 | 3.90% |
| 2015-12-31 | 2.42% |
| 2014-12-31 | 1.98% |
| 2013-12-31 | 0.00% |
